[1] [1] Ay S, Eryilmaz MA, Aksoy N, et al. Is early detection of colon cancer possible with red blood cell distribution width?[J]. Asian Pac J Cancer Prev, 2015, 16(2): 753-756.

[2] [2] Audisio A, Fazio R, Dapr V, et al. Neoadjuvant chemotherapy for early-stage colon cancer[J]. Cancer Treat Rev, 2024, 123: 102676.

[5] [5] Zeng ZM, Du HY, Xiong L, et al. BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest[J]. Life Sci, 2020, 244: 117342.

[6] [6] Chen Y, Nakanishi M, Bautista EJ, et al. Colon cancer prevention with walnuts: a longitudinal study in mice from the perspective of a gut enterotype-like cluster[J]. Cancer Prev Res (Phila), 2020, 13(1): 15-24.

[8] [8] Mirman Z, Sasi NK, King A, et al. 53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Pol-primase fillin synthesis[J]. Nat Cell Biol, 2022, 24(1): 51-61.

[10] [10] Ondee S, Sithisarn P, Mangmool S, et al. Chemical standardization and anti-proliferative activity ofardisia ellipticafruit against the HCT116 human colon cancer cell line[J]. Molecules, 2020, 25(5): 1023.

[11] [11] Zhang L, Li Z, Skrzypczynska KM, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer[J]. Cell, 2020, 181(2): 442-459. e29.

[15] [15] Ando N, Hara M, Shiga K, et al. Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL6 and VEGF from colon cancer-associated fibroblasts[J]. Oncol Rep, 2019, 42(1): 339-349.

[16] [16] Zhou X, Jin J, Wang W, et al. Efficacy and adverse reactions of combination therapy of bevacizumab and 5-fluorouracil in patients with metastatic colon cancer[J]. J BUON, 2019, 24(2): 494-500.

[17] [17] Yang L, Wei W, Zhou L, et al. High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma: A systematic meta-analysis from 21 studies[J]. Medicine (Baltimore), 2019, 98(21): e15641.